Table 3.

Factors associated with relapse to insulin requirement among unprovoked A-β+ KPD patients within one year of the index DKA episode - univariate analysis.

	N	Odds Ratio	Standard Error	95% CI	P
Age	50	0.95	0.03	0.898–0.999	0.03
Sex	50	0.97	0.61	0.284–3.302	0.96
Race – African-American	50	0.31	0.32	0.042–2.302	0.51
Race-Hispanic		0.43	0.43	0.059–3.090
Family history of diabetes	50	0.97	0.65	0.265–3.573	0.97
BMI	50	1.03	0.04	0.961–1.097	0.44
HOMA2-%B at baseline	40	1.00	0.01	0.986–1.020	0.76
HOMA2-%B at 1 year	37	0.98	0.01	0.969–0.995	0.00
HOMA2-IR at baseline	40	0.75	0.21	0.434–1.306	0.25
HOMA2-IR at 1 year	37	0.58	0.17	0.324–1.047	0.05
HbA1c at baseline	46	0.87	0.11	0.685–1.099	0.23
HbA1c at 1 year	46	1.71	0.42	1.052–2.778	0.00
Fasting C-peptide at baseline	50	0.91	0.20	0.595–1.383	0.63
Fasting C-peptide at 1 year	37	0.99	0.22	0.639–1.526	0.95
DRB1*04	35	1.16	0.99	0.216–6.207	0.86
DRB1*07	35	0.71	0.67	0.111–4.511	0.71
DRB1*15	35	0.42	0.38	0.071–2.449	0.31
% change in HOMA2-%B (odds ratio for every 10% change)	42	0.97	0.01	0.94–1.00	0.03
% change in HOMA-IR (odds ratio for every 10% change)	42	0.98	0.02	0.94–1.03	0.41
% change in HbA1c (odds ratio for every 10% change)	44	1.95	0.51	1.16–3.27	0.01
% change in fasting C-peptide (odds ratio for every 10% change)	37	0.94	0.05	0.85–1.04	0.21